TXG (10x Genomics, Inc. Class A Common Stock) Stock Analysis - Analyst Ratings

10x Genomics, Inc. Class A Common Stock (TXG) is a publicly traded Healthcare sector company. As of May 21, 2026, TXG trades at $23.71 with a market cap of $2.72B and a P/E ratio of -137.82. TXG moved +7.58% today. Year to date, TXG is +30.90%; over the trailing twelve months it is +164.10%. Its 52-week range spans $6.78 to $26.45. Analyst consensus is buy with an average price target of $24.10. Rallies surfaces TXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate TXG?

12 analysts cover TXG: 0 strong buy, 4 buy, 8 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $24.10.

TXG Key Metrics

Key financial metrics for TXG
MetricValue
Price$23.71
Market Cap$2.72B
P/E Ratio-137.82
EPS$-0.17
Dividend Yield0.00%
52-Week High$26.45
52-Week Low$6.78
Volume32
Avg Volume0
Revenue (TTM)$638.78M
Net Income$-22.66M
Gross Margin69.60%

TXG Analyst Consensus

12 analysts cover TXG: 0 strong buy, 4 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $24.10.

Latest TXG News

Recent TXG Insider Trades

  • Saxonov Serge sold 5.00K (~$122.78K) on Apr 14, 2026.
  • Saxonov Serge sold 5.00K (~$97.61K) on Mar 24, 2026.
  • Saxonov Serge sold 10.00K (~$191.30K) on Mar 23, 2026.

Common questions about TXG

What do analysts rate TXG?
12 analysts cover TXG: 0 strong buy, 4 buy, 8 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $24.10.
Does Rallies show TXG price targets?
Yes. Rallies tracks TXG analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is TXG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TXG. It does not provide personalized investment advice.
TXG

TXG